Skip to main content
. 2021 Aug 28;10(9):1379. doi: 10.3390/antiox10091379

Figure 1.

Figure 1

Flowchart of study progress. GLP-1RA: glucagon-like peptide-1 receptor agonists; SGLT-2i: sodium-glucose cotransporter-2 inhibitors.